Skip to main content

Table 4 Summary of Androgen deficiency in the aging male (ADAM) scoring by visit and treatment

From: A double blind, placebo-controlled randomized comparative study on the efficacy of phytosterol-enriched and conventional saw palmetto oil in mitigating benign prostate hyperplasia and androgen deficiency

Visit Observed value Change from baseline
Intervention
(VISPO)
n = 33
Comparator
(SPO)
n = 33
Placebo
n = 33
p-value** Intervention
(VISPO)
n = 33
p-value* Comparator
(SPO)
n = 33
p-value* Placebo
n = 33
p-value* p-value**
Visit 1 4.33 ± 1.67 4.15 ± 1.68 4.30 ± 1.76 0.898(1)  
Visit 2 3.97 ± 1.74 4.12 ± 1.69 4.48 ± 1.73 0.461(1) −0.36 ± 0.70a 0.005 −0.03 ± 0.53ab 0.744 0.18 ± 0.68b 0.136 0.007(2)
Visit 3 3.73 ± 1.74 4.21 ± 1.43 4.45 ± 1.64 0.179(1) −0.61 ± 1.06a 0.002 0.06 ± 0.90b 0.701 0.15 ± 0.94b 0.361 0.003(1)
  1. Data are presented as Mean ± SD; n = No of subjects
  2. a-b values within a row with different superscript letters differ (p < 0.05), as analysed by one-way ANOVA
  3. *p values were compared within each group from baseline using paired t test
  4. **p values were compared between groups
  5. 1)P values were derived from ANOVA, and Scheffe test was used to post hoc test
  6. 2)P values were derived from Kruskal-Wallis test, and Dunnett T3 test was used to post hoc test